1.
JTM’s Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section
Adrian
Bot,
Francesco
Marincola,
Pedro
Romero
Journal of Translational Medicine 2013, 11 :2 (4 January 2013)
Abstract | Full text | PDF | PubMed
2.
Cancer classification using the Immunoscore: a worldwide task force
Jérôme
Galon,
Franck
Pagès,
Francesco
M
Marincola,
Helen
K
Angell,
Magdalena
Thurin,
Alessandro
Lugli,
Inti
Zlobec,
Anne
Berger,
Carlo
Bifulco,
Gerardo
Botti,
Fabiana
Tatangelo,
Cedrik
M
Britten,
Sebastian
Kreiter,
Lotfi
Chouchane,
Paolo
Delrio,
Hartmann
Arndt,
Martin
Asslaber,
Michele
Maio,
Giuseppe
V
Masucci,
Martin
Mihm,
Fernando
Vidal-Vanaclocha,
James
P
Allison,
Sacha
Gnjatic,
Leif
Hakansson,
Christoph
Huber,
Harpreet
Singh-Jasuja,
Christian
Ottensmeier,
Heinz
Zwierzina,
Luigi
Laghi,
Fabio
Grizzi
et al.
Journal of Translational Medicine 2012, 10 :205 (3 October 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
3.
Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011
Ivan
Forero,
Hideho
Okada,
Suzanne
L
Topalian,
Thomas
F
Gajewski,
Alan
J
Korman,
Ignacio
Melero
Journal of Translational Medicine 2012, 10 :108 (28 May 2012)
Abstract | Full text | PDF | PubMed
4.
SITC 26th annual meeting – summary
Emanuela
Romano,
Denise
Nardelli-Haefliger,
Alena
Donda,
Stephanie
Corgnac,
Pedro
Romero
Journal of Translational Medicine 2012, 10 :105 (23 May 2012)
Abstract | Full text | PDF | PubMed
5.
The immune score as a new possible approach for the classification of cancer
Jérôme
Galon,
Franck
Pagès,
Francesco
M
Marincola,
Magdalena
Thurin,
Giorgio
Trinchieri,
Bernard
A
Fox,
Thomas
F
Gajewski,
Paolo
A
Ascierto
Journal of Translational Medicine 2012, 10 :1 (3 January 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
6.
Defining the critical hurdles in cancer immunotherapy
Bernard
A
Fox,
Dolores
J
Schendel,
Lisa
H
Butterfield,
Steinar
Aamdal,
James
P
Allison,
Paolo
Ascierto,
Michael
B
Atkins,
Jirina
Bartunkova,
Lothar
Bergmann,
Neil
Berinstein,
Cristina
C
Bonorino,
Ernest
Borden,
Jonathan
L
Bramson,
Cedrik
M
Britten,
Xuetao
Cao,
William
E
Carson,
Alfred
E
Chang,
Dainius
Characiejus,
A Raja
Choudhury,
George
Coukos,
Tanja
de Gruijl,
Robert
O
Dillman,
Harry
Dolstra,
Glenn
Dranoff,
Lindy
G
Durrant,
James
H
Finke,
Jerome
Galon,
Jared
A
Gollob,
Cécile
Gouttefangeas,
Fabio
Grizzi
et al.
Journal of Translational Medicine 2011, 9 :214 (14 December 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
7.
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery
Davide
Bedognetti,
James
M
Balwit,
Ena
Wang,
Mary
L
Disis,
Cedrik
M
Britten,
Lucia
G
Delogu,
Sara
Tomei,
Bernard
A
Fox,
Thomas
F
Gajewski,
Francesco
M
Marincola,
Lisa
H
Butterfield
Journal of Translational Medicine 2011, 9 :155 (19 September 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
8.
Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer
James
M
Balwit,
Pawel
Kalinski,
Vernon
K
Sondak,
Pierre
G
Coulie,
Elizabeth
M
Jaffee,
Thomas
F
Gajewski,
Francesco
M
Marincola
Journal of Translational Medicine 2011, 9 :60 (12 May 2011)
Abstract | Full text | PDF | PubMed
9.
The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program
James
M
Balwit,
Patrick
Hwu,
Walter
J
Urba,
Francesco
M
Marincola
Journal of Translational Medicine 2011, 9 :18 (31 January 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
10.
Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
Lisa
H
Butterfield,
Mary
L
Disis,
Samir
N
Khleif,
James
M
Balwit,
Francesco
M
Marincola
Journal of Translational Medicine 2010, 8 :130 (7 December 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
The Society for Immunotherapy of Cancer (SITC) is a non-profit society of medical professionals dedicated to improving cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy.
